Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 3 2Phase 2 1Phase 1 1

Status

Recruiting 6Completed 5Active not recruiting 5Terminated 4Withdrawn 1Unknown 1

Sponsor Class

OTHER 4INDUSTRY 2

Study Type

Interventional 6

Sponsor

Cancer Type

Other hematologic neoplasm 6Lymphoid 1

Conditions

Prostatic Neoplasms 18Neoplasms 18Breast Neoplasms 16Colorectal Neoplasms 11Carcinoma, Non-Small-Cell Lung 11Lung Neoplasms 9Squamous Cell Carcinoma of Head and Neck 7Urinary Bladder Neoplasms 6Hematopoietic and Lymphatic System Neoplasm 6Hematologic Neoplasms 6Ovarian Neoplasms 5Neoplasm Metastasis 5Triple Negative Breast Neoplasms 4Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Pancreatic Neoplasms 3Multiple Myeloma 3Mouth Neoplasms 3Leukemia, Myeloid, Acute 3Hematopoietic and Lymphoid System Neoplasm 3Fallopian Tube Neoplasms 3Carcinoma, Renal Cell 3Sarcoma 2Radiodermatitis 2Peritoneal Neoplasms 2Pathologic Complete Response 2Motor Activity 2Melanoma 2Malignant Solid Neoplasm 2Hemangiosarcoma 2Head and Neck Neoplasms 2

Interventions

Cyclophosphamide 22fludarabine 20venetoclax 8Whole-Body Irradiation 8Mycophenolic Acid 8Standard of Care 6Mesna 6Melphalan 6Azacitidine 6fludarabine phosphate 5Sirolimus 5thymoglobulin 4Thiotepa 4Tacrolimus 4Surveys and Questionnaires 4Specimen Handling 4Filgrastim 4Cytarabine 4entrectinib 3daratumumab 3cobimetinib 3alectinib 3Vemurafenib 3Rituximab 3Practice Guidelines as Topic 3Palliative Care 3Granulocyte Colony-Stimulating Factor 3Busulfan 3Bortezomib 3Blood Specimen Collection 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Recruiting × Hematologic Neoplasms × Standard of Care × Clear all
NCT03486873 2026-05-26

MK-3475-587

Merck Sharp & Dohme LLC

Phase 3 Recruiting
3,500 enrolled
Other hematologic neoplasm

Hematologic Neoplasms

NCT04844866 2026-04-29

DALY 2-EU

Miltenyi Biomedicine GmbH

Phase 2 Recruiting
213 enrolled
LymphoidOther hematologic neoplasm

Lymphoma, Non-Hodgkin, Lymphoma, Large B-Cell, Diffuse, Hematologic Neoplasms

NCT07203534 2026-03-24

ONC-MM-2407: The Effect of Virtual Reality Headsets on Pain and Anxiety in the Peri and Post Bone Marrow Biopsy Period

Wake Forest University Health Sciences

Phase NA Recruiting
160 enrolled
Other hematologic neoplasm

Hematologic Neoplasms

NCT07186192 2026-01-28

Digital Health Intervention for Self-Management and Telemonitoring in Chimeric Antigen Receptor (CAR-T) Therapy

City of Hope Medical Center

Phase 3 Recruiting
190 enrolled
Other hematologic neoplasm

Hematologic Neoplasms

NCT02962661 2026-01-07

Donor Bone Marrow Derived Mesenchymal Stem Cells in Controlling Heart Failure in Patients With Cardiomyopathy Caused by Anthracyclines

M.D. Anderson Cancer Center

Phase 1 Recruiting
72 enrolled
Other hematologic neoplasm

Heart Failure, Cardiomyopathies, Hematologic Neoplasms

NCT06089408 2025-08-08

Weighted Blanket Use to Reduce Anxiety in Oncology Patients

Ohio State University Comprehensive Cancer Center

Phase NA Recruiting
114 enrolled
Other hematologic neoplasm

Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡